Stock Scorecard



Stock Summary for Smith & Nephew plc (SNN) - $28.37 as of 5/5/2025 9:13:53 PM EST

Total Score

15 out of 30

Safety Score

46 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for SNN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SNN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SNN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SNN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for SNN (46 out of 100)

Stock Price Rating (Max of 10) 7
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 6
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for SNN

Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland 5/5/2025 6:00:00 AM
Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio - Elutia ( NASDAQ:ELUT ) 5/1/2025 8:05:00 PM
Is Smith & Nephew SNATS ( SNN ) a Great Value Stock Right Now? 4/29/2025 1:40:00 PM
New Strong Buy Stocks for April 29th 4/29/2025 10:24:00 AM
EMEA Growth & Product Launches to Support Boston Scientific Stock 4/28/2025 5:26:00 PM
International Growth Drives GMED Stock Amid Fierce Competition 4/14/2025 4:18:00 PM
International Expansion, Product Launches Support BSX Stock 3/27/2025 4:01:00 PM
Should You Hold Globus Medical Stock in Your Portfolio Now? 3/19/2025 2:02:00 PM
New Product Launches Benefit GMED Stock Amid Macro Issues 3/18/2025 3:29:00 PM
Bone Cement Market Sales on Track for US$ 1.2 Billion by 2035, Expanding at 5.2% CAGR with Rising Demand for Orthopedic Surgeries - Analysis by Transparency Market Research 3/17/2025 3:26:00 PM

Financial Details for SNN

Company Overview

Ticker SNN
Company Name Smith & Nephew plc
Country USA
Description Smith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom.
Sector Name LIFE SCIENCES
Industry Name ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Most Recent Quarter 12/31/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 28.37
Price 4 Years Ago 31.31
Last Day Price Updated 5/5/2025 9:13:53 PM EST
Last Day Volume 811,339
Average Daily Volume 1,084,628
52-Week High 30.91
52-Week Low 23.30
Last Price to 52 Week Low 21.76%

Valuation Measures

Trailing PE 29.81
Industry PE 33.38
Sector PE 37.03
5-Year Average PE 47.18
Free Cash Flow Ratio 20.12
Industry Free Cash Flow Ratio 36.38
Sector Free Cash Flow Ratio 29.42
Current Ratio Most Recent Quarter 2.89
Total Cash Per Share 1.41
Book Value Per Share Most Recent Quarter 6.03
Price to Book Ratio 2.24
Industry Price to Book Ratio 4.02
Sector Price to Book Ratio 21.93
Price to Sales Ratio Twelve Trailing Months 2.11
Industry Price to Sales Ratio Twelve Trailing Months 5.30
Sector Price to Sales Ratio Twelve Trailing Months 28.34
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 437,514,000
Market Capitalization 12,412,272,180
Institutional Ownership N/A

Dividends

Ex-Dividend Date 3/28/2025
Previous Dividend Amount 0.2880
Current Dividend Amount 0.4620
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.75
Trailing Annual Dividend Yield 2.66%
Forward Annual Dividend Rate 0.92
Forward Annual Dividend Yield 3.27%
5-Year Dividend Payments Count 10
3-Year Average Dividend Yield 3.10%
5-Year Average Dividend Yield 2.84%
1-Year Dividend Growth Rate Percentage 23.20%
3-Year Dividend Growth Rate Percentage 11.00%
5-Year Dividend Growth Rate Percentage 5.35%
All-Time Dividend Growth Rate Percentage 5.61%
Dividend Payout Ratio 79.79%

Income Statement

Quarterly Earnings Growth YOY 116.40%
Annual Earnings Growth 56.65%
Reported EPS 12 Trailing Months 0.94
Reported EPS Past Year 0.00
Reported EPS Prior Year 0.35
Net Income Twelve Trailing Months 610,000,000
Net Income Past Year 412,000,000
Net Income Prior Year 263,000,000
Quarterly Revenue Growth YOY 6.00%
5-Year Revenue Growth 2.49%
Operating Margin Twelve Trailing Months 18.70%

Balance Sheet

Total Cash Most Recent Quarter 619,000,000
Total Cash Past Year 619,000,000
Total Cash Prior Year 302,000,000
Net Cash Position Most Recent Quarter -2,504,000,000
Net Cash Position Past Year -2,504,000,000
Long Term Debt Past Year 3,123,000,000
Long Term Debt Prior Year 2,175,000,000
Total Debt Most Recent Quarter 3,123,000,000
Equity to Debt Ratio Past Year 0.63
Equity to Debt Ratio Most Recent Quarter 0.63
Total Stockholder Equity Past Year 5,265,000,000
Total Stockholder Equity Prior Year 5,217,000,000
Total Stockholder Equity Most Recent Quarter 5,265,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 874,000,000
Free Cash Flow Per Share Twelve Trailing Months 2.00
Free Cash Flow Past Year 606,000,000
Free Cash Flow Prior Year 181,000,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.12
MACD Signal -0.17
20-Day Bollinger Lower Band 22.64
20-Day Bollinger Middle Band 26.03
20-Day Bollinger Upper Band 29.43
Beta 0.65
RSI 62.06
50-Day SMA 26.64
150-Day SMA 25.85
200-Day SMA 27.27

System

Modified 5/3/2025 10:30:35 AM EST